Stock Trading Ideas

TSMC Triggers Death Cross As Trump Tariff Threats Add To Investor Concerns
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
Trump Torpedoes US Steel Deal, X Stock Tumbles Despite Bullish Chart
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
Trump Torpedoes US Steel Deal, X Stock Tumbles Despite Bullish Chart
US Stocks Likely To Open Lower Ahead Of March Inflation Release: Expert Highlights 'Fairly Weak Returns' After 5%+ Gains In S&P 500
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline

Trading Ideas Recent News

EXCLUSIVE: Stephanie Link Is Buying These 5 'Best In Breed' Stocks As Markets Whipsaw
Hightower Advisors' Stephanie Link has been holding her nose and buying stocks in recent weeks as markets unwind amid tariff uncertainty.
Gold Fever Grips Wall Street: These ETFs Are Striking It Rich
The gold rush continues as investors turn to ETFs for exposure to the metal amid geopolitical tensions and market volatility.
Amazon, Wayfair, Pinterest Win Analyst Backing Due To Tariff Pause, Supply Chain Relief, Discretionary Spend Recovery
If the Street can anticipate a resolution to all tariff issues over the next 12-18 months, the analyst notes the most significant opportunity for certain names in his e-commerce coverage group.
Goldman Sachs Hits The Brakes: Auto Tariffs & Slumping Demand May Shake Up Ford, Tesla, Rivian, Lear & Visteon
Goldman Sachs slashes auto outlook, downgrades Ford, Lear & Visteon as tariffs and weak demand drag down Tesla, Rivian, and sector stocks.
Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan
Keros Therapeutics launches strategic review and adopts rights plan after investor activity signals potential changes in company control.
Dollar Spoiling The Party, Inflation Anomaly But Storm Ahead, The Real Reason Trump Reversed
Is the U.S. losing its safe haven status? Is this the real reason behind President Trump's quick reversal on tariffs?
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
Tempest Therapeutics hires MTS Health to explore M&A and partnerships after Roche shows limited interest in its liver cancer program.
Stock Of The Day – Is Microsoft Going To Lead The Magnificent Seven Higher?
Shares of Microsoft (MSFT) have rallied back to their 40-da7 moving average. Some would suggest this makes it the strongest Maj 7 stock.
Walmart's Strong Outlook Driven By 3 Strategic Advantages, Analyst Says
Walmart's investor day highlighted positive ecommerce growth, with a Buy rating and $106 price target from analyst Kate McShane.
Wells Fargo Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
How To Trade SPY, As Inflation Cools In March
How to trade the SPY and leading tech stocks, as inflation eases for a second straight month in March.
Dow Tumbles Over 800 Points; US Inflation Rate Falls In March
Top 2 Real Estate Stocks That May Keep You Up At Night This Month
Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved